The Clorox Company (NYSE:CLX) Shares Sold by Invesco Ltd.

Invesco Ltd. cut its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 1.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,267,339 shares of the company's stock after selling 20,091 shares during the quarter. Invesco Ltd. owned approximately 1.02% of Clorox worth $205,829,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. California Public Employees Retirement System grew its position in shares of Clorox by 1.3% during the 4th quarter. California Public Employees Retirement System now owns 565,810 shares of the company's stock worth $91,893,000 after buying an additional 6,987 shares in the last quarter. Fifth Third Wealth Advisors LLC purchased a new position in Clorox during the fourth quarter valued at approximately $204,000. Apollon Wealth Management LLC lifted its holdings in Clorox by 119.6% during the fourth quarter. Apollon Wealth Management LLC now owns 3,364 shares of the company's stock worth $546,000 after buying an additional 1,832 shares during the period. Miracle Mile Advisors LLC bought a new stake in Clorox during the 4th quarter valued at $1,566,000. Finally, Geode Capital Management LLC raised its position in shares of Clorox by 1.1% in the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company's stock worth $491,713,000 after acquiring an additional 33,970 shares in the last quarter. Institutional investors own 78.53% of the company's stock.

Clorox Price Performance

Shares of CLX stock traded up $2.52 on Thursday, reaching $139.32. 218,509 shares of the company were exchanged, compared to its average volume of 1,296,660. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The business has a 50-day moving average price of $146.89 and a 200 day moving average price of $156.79. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The company has a market cap of $17.16 billion, a price-to-earnings ratio of 38.06, a P/E/G ratio of 2.62 and a beta of 0.61.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the business posted $2.16 earnings per share. Equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.50%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's dividend payout ratio is presently 133.33%.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on CLX. Wells Fargo & Company lowered their price target on shares of Clorox from $155.00 to $145.00 and set an "equal weight" rating on the stock in a report on Wednesday. Barclays decreased their price target on Clorox from $139.00 to $134.00 and set an "underweight" rating for the company in a research note on Friday, April 11th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. StockNews.com lowered Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Finally, JPMorgan Chase & Co. dropped their target price on Clorox from $173.00 to $151.00 and set a "neutral" rating on the stock in a research report on Friday, April 11th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $154.25.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.